| scholarly article | Q13442814 |
| P50 | author | Zhihui Hao | Q90636531 |
| P2093 | author name string | Peng Wang | |
| Longfei Hu | |||
| P2860 | cites work | Plasmid-mediated quinolone resistance: a multifaceted threat | Q24645356 |
| Enzyme structural plasticity and the emergence of broad-spectrum antibiotic resistance | Q27649912 | ||
| Mechanistic and Structural Analysis of Aminoglycoside N -Acetyltransferase AAC(6′)-Ib and Its Bifunctional, Fluoroquinolone-Active AAC(6′)-Ib-cr Variant † ‡ | Q27651667 | ||
| Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance | Q27664216 | ||
| Structural insights into quinolone antibiotic resistance mediated by pentapeptide repeat proteins: conserved surface loops direct the activity of a Qnr protein from a Gram-negative bacterium | Q27666560 | ||
| Structure of QnrB1, a Plasmid-mediated Fluoroquinolone Resistance Factor | Q27667906 | ||
| LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions | Q27861128 | ||
| Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries. | Q30240591 | ||
| Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase | Q33556397 | ||
| Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV | Q33883611 | ||
| QnrS1 structure-activity relationships | Q33909989 | ||
| Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria | Q34010692 | ||
| Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae | Q34434110 | ||
| The worldwide emergence of plasmid-mediated quinolone resistance | Q34569740 | ||
| Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China | Q34605549 | ||
| Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria | Q34647294 | ||
| Clinical importance and epidemiology of quinolone resistance | Q34838791 | ||
| Plasmid-mediated quinolone resistance | Q34888920 | ||
| Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China | Q35102456 | ||
| Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. | Q35107937 | ||
| Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance | Q35682250 | ||
| New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate | Q36094929 | ||
| Mechanisms of drug resistance: quinolone resistance | Q36225422 | ||
| Identification of new bacteria harboring qnrS and aac(6')-Ib/cr and mutations possibly involved in fluoroquinolone resistance in raw sewage and activated sludge samples from a full-scale WWTP. | Q36226865 | ||
| Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance | Q36783606 | ||
| Quinolone-mediated bacterial death. | Q36921143 | ||
| Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France | Q36932963 | ||
| Mutational analysis of quinolone resistance protein QnrB1. | Q37263562 | ||
| oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae | Q37274700 | ||
| Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro. | Q37335894 | ||
| Quinolones: action and resistance updated | Q37595559 | ||
| Mechanism of quinolone action and resistance | Q37701591 | ||
| Plasmids and the spread of resistance | Q38090172 | ||
| Plasmid-mediated quinolone resistance--current knowledge and future perspectives | Q38097417 | ||
| Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success | Q38212925 | ||
| Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma. | Q38694652 | ||
| Coexistence of plasmid-mediated quinolone resistance determinants and AmpC-Beta-Lactamases in Escherichia coli strains in Egypt | Q38852946 | ||
| Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance | Q38906198 | ||
| Plasmid-mediated quinolone resistance: Two decades on. | Q39027430 | ||
| Mechanisms of quinolone action and resistance: where do we stand? | Q39306821 | ||
| Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies | Q40788996 | ||
| Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. | Q41008865 | ||
| Functional verification of computationally predicted qnr genes. | Q41851848 | ||
| Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli. | Q42201141 | ||
| Effect of the efflux pump inhibitor Phe-Arg-beta-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. | Q43968989 | ||
| Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. | Q44266033 | ||
| Prevalence of quinolone resistance mechanisms in Enterobacteriaceae producing acquired AmpC β-lactamases and/or carbapenemases in Spain. | Q46526994 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Pterostilbene, a potential MCR-1 inhibitor that enhances the efficacy of polymyxin B. | Q50020741 | ||
| Rapid detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae by MALDI-TOF MS analysis. | Q50963299 | ||
| Novel Ciprofloxacin-Modifying Enzyme (CrpP) Encoded by the Pseudomonas aeruginosa pUM505 Plasmid. | Q52629698 | ||
| Magnolol restores the activity of meropenem against NDM-1-producing Escherichia coli by inhibiting the activity of metallo-beta-lactamase. | Q52659220 | ||
| Complete Sequences and Characterization of Two Novel Plasmids Carrying aac(6')-Ib-cr and qnrS Gene in Shigella flexneri. | Q53813391 | ||
| Our Evolving Understanding of the Mechanism of Quinolones. | Q54237618 | ||
| Mechanism of action of and resistance to quinolones | Q58057075 | ||
| Characterization of the complete sequences and stability of plasmids carrying the genes aac(6')-Ib-cr or qnrS in Shigella flexneri in the Hangzhou area of China | Q64137696 | ||
| Plasmid-mediated quinolone resistance | Q82262149 | ||
| Prevalence of the crpP gene conferring decreased ciprofloxacin susceptibility in enterobacterial clinical isolates from Mexican hospitals | Q91501743 | ||
| Palmatine: A review of its pharmacology, toxicity and pharmacokinetics | Q91733285 | ||
| Subtle Difference Generates Big Dissimilarity: Comparison of Enzymatic Activity in KL1 and KL2 Domains of Lancelet Klotho | Q91753710 | ||
| Quercetin protects rats from catheter-related Staphylococcus aureus infections by inhibiting coagulase activity | Q92062548 | ||
| Discovery of a potential MCR-1 inhibitor that reverses polymyxin activity against clinical mcr-1-positive Enterobacteriaceae | Q92240463 | ||
| Theaflavin-3,3´-digallate increases the antibacterial activity of β-lactam antibiotics by inhibiting metallo-β-lactamase activity | Q92491672 | ||
| Transferable Mechanisms of Quinolone Resistance from 1998 Onward | Q92622654 | ||
| Palmatine inhibits Zika virus infection by disrupting virus binding, entry, and stability | Q93034141 | ||
| Plasmid-mediated quinolone resistance: Mechanisms, detection, and epidemiology in the Arab countries | Q93166473 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 749-759 | |
| P577 | publication date | 2020-03-09 | |
| P1433 | published in | Infection and Drug Resistance | Q15716352 |
| P1476 | title | Palmatine Is a Plasmid-Mediated Quinolone Resistance (PMQR) Inhibitor That Restores the Activity of Ciprofloxacin Against QnrS and AAC(6')-Ib-cr-Producing Escherichia coli | |
| P478 | volume | 13 |
Search more.